Elevance Health (ELV) Q4 2024 Annual Earnings
Elevance Health reported Q4 2024 revenue of $45.4B, beat analyst consensus of $45.0B by $489.5M. Diluted EPS came in at $3.84, beat the $3.80 consensus by $0.04. Elevance Health reports across 3 business segments, led by Health Benefits, CarelonRx, and Carelon Services.
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Elevance Health's Q4 2024 earnings report.
Elevance Health (ELV) reported Q4 2024 earnings on January 23, 2025 before market open.
Elevance Health reported revenue of $45.4B and diluted EPS of $3.84 for Q4 2024.
Revenue beat the consensus estimate of $45.0B by $489.5M. EPS beat the consensus estimate of $3.80 by $0.04.
You can read the 10-K periodic report (0001156039-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.